"ICAPO works to ensure that member countries abide by their OECD treaty obligations, which obligate member countries to accept data from OECD-approved test guidelines instead of requiring duplicative animal testing."
ICAPO currently brings its technical and policy expertise to bear in the following OECD activities:
- Working Group of National Co-ordinators of the Test Guidelines Programme
- Task Force on Endocrine Disrupter Testing and Assessment
- Task Force on Existing Chemicals, including (Q)SAR
- Validation Management Group for Non-Animal testing
- Validation Management Group for Mammalian testing
ICAPO carries out its work at the OECD by participating in relevant OECD meetings and working groups, commenting on OECD draft test guidelines and other documents, and nominating outside experts to take part in OECD activities on ICAPO's behalf. ICAPO also works to ensure that member countries abide by their OECD treaty obligations under the Mutual Acceptance of Data provision, which obligates member countries to accept data from OECD-approved test guidelines instead of requiring duplicative animal testing.
Recently, ICAPO members formed a sister coalition—ICAPPP—to promote animal protection in pharmaceutical testing guidelines developed internationally through tripartite discussions among Japan, Europe, and the United States under the banner of the International Conference on Harmonisation (ICH) and other similar harmonization programmes.
ICAPO welcomes inquiries from outside experts interested in working on ICAPO's behalf on OECD-related activities. Please contact the ICAPO secretariat for more information.